A Chinese biotechnology company developing regenerative islet tissue for diabetes treatment
A Chinese biotechnology company developing regenerative islet tissue for diabetes treatment. It focuses on improving stem-cell in-vitro differentiation into pancreatic islet tissue and scaling production of tissue designed to avoid tumor formation while retaining full in-vivo function.